Canadians File Vioxx Class Action

October 8, 2004
Lawyers representing Canadians who used the popular arthritis and pain-killer drug Vioxx today filed a national class on behalf of Vioxx users who suffered heart attacks, strokes and other complications.

Related Stories • Court Snuffs Vioxx Suit • Pfizer Pays $894 Million to Settle NSAID Claims • Researchers Claim Vioxx Safety Study Was Actually Marketing Plan • First Vioxx Judgment Overturned On Appeal • Merck Agrees to Pay $58 Million to Settle Vioxx Claims • Researchers Claim Merck Cooked Vioxx Data • Common Pain Relievers May Boost Muscle Mass • More Painkillers Can Cause More Pain • Merck Caves, Agrees To $4.85 Billion Vioxx Settlement • New York Sues Vioxx Maker over Drug’s Risks • Merck Wins Vioxx Case In Illinois • Judge Rules Out Vioxx "Super" Class Action • FDA Critic Blasts Merck's Vioxx Replacement • Merck Loses New Orleans Vioxx Case • Merck Wins Latest Vioxx Suit • Vioxx Study Authors Backtrack On Claim • Older Painkillers May Increase Heart Attack Risk • More about Vioxx --- Other NSAIDs • Bextra • Celebrex • Dangers of Other Vioxx-Type Drugs • Vioxx Alternatives • Aleve Ingredient Seen as Health Risk

Two Vioxx users, who each sustained massive heart attacks that required surgical intervention following their ingestion of Vioxx, have agreed to act as representative plaintiffs.

"I am simply astonished that in this day and age this drug company kept selling the drug making huge profits even when they knew of the serious increased risk of heart attack and stroke," said Mary Jane McNicholl, a Toronto heart attack victim and one of the representative Plaintiffs. "This kind of thing should not be permitted in Canada."

A statement of claim has been issued in the Ontario Superior Court of Justice seeking a National Class Action. Four other class actions have been commenced in Quebec, together with claims in British Columbia, Ontario and Saskatchewan within the past week.

Vioxx was withdrawn from the worldwide market September 30, 2004, following continuing reports and studies that found patients using Vioxx faced a significantly higher risk of cardiovascular complications, including heart attack, stroke, angina, blood clots and congestive heart failure.

Launched in Canada in October 1999, in 2000 reports surfaced linking the drug to an alarming series of associated complications, including increased risk of heart attack and other cardiovascular complications, as well as liver damage, kidney damage and lack of bone healing.

"Other drug companies must be forced to be more conscientious to make sure they thoroughly test all drugs before they are released for human consumption and after they are released - look at devastating results when the companies don't act responsibly. It ruins lives," said James Venables, a Calgary resident and heart attack victim.

In Australia, a Brisbane law firm says it has begun assembling a class action. It's estimated up to 700,000 Australians may be using Vioxx.

Australia's Therapeutic Goods Administration says one-in-65 users may be affected after taking the drug for more than 18 months.

Report Your Experience
If you've had a bad experience -- or a good one -- with a consumer product or service, we'd like to hear about it. All complaints are reviewed by class action attorneys and are considered for publication on our site. Knowledge is power! Help spread the word. File your consumer report now.

Back to the top |

Terms of Use Your use of this site constitutes acceptance of the Terms of Use

Advertisements on this site are placed and controlled by outside advertising networks. ConsumerAffairs.com does not evaluate or endorse the products and services advertised. See the FAQ for more information.

Company Response Welcome If complaints about your company appear on our site, we welcome your response. Please see the Response Form for more information.

For more information, see the FAQ and privacy policy. The information on this Web site is general in nature and is not intended as a substitute for competent legal advice.  ConsumerAffairs.com Inc. makes no representation as to the accuracy of the information herein provided and assumes no liability for any damages or loss arising from the use thereof. 

Copyright © 2003-2009 ConsumerAffairs.com Inc.  All Rights Reserved.    The contents of this site may not be republished, reprinted, rewritten or recirculated without written permission.